Literature DB >> 26552704

Filamin A Expression Negatively Regulates Sphingosine-1-Phosphate-Induced NF-κB Activation in Melanoma Cells by Inhibition of Akt Signaling.

Ludmila S Campos1, Yamila I Rodriguez1, Andreia M Leopoldino2, Nitai C Hait3, Pablo Lopez Bergami4, Melina G Castro1, Emilse S Sanchez1, Michael Maceyka3, Sarah Spiegel5, Sergio E Alvarez6.   

Abstract

Sphingosine-1-phosphate (S1P) is a bioactive lipid mediator that regulates many processes in inflammation and cancer. S1P is a ligand for five G-protein-coupled receptors, S1PR1 to -5, and also has important intracellular actions. Previously, we showed that intracellular S1P is involved in tumor necrosis factor alpha (TNF)-induced NF-κB activation in melanoma cell lines that express filamin A (FLNA). Here, we show that extracellular S1P activates NF-κB only in melanoma cells that lack FLNA. In these cells, S1P, but not TNF, promotes IκB kinase (IKK) and p65 phosphorylation, IκBα degradation, p65 nuclear translocation, and NF-κB reporter activity. NF-κB activation induced by S1P was mediated via S1PR1 and S1PR2. Exogenous S1P enhanced the phosphorylation of protein kinase Cδ (PKCδ), and its downregulation reduced S1P-induced the phosphorylation of IKK and p65. In addition, silencing of Bcl10 also inhibited S1P-induced IKK phosphorylation. Surprisingly, S1P reduced Akt activation in melanoma cells that express FLNA, whereas in the absence of FLNA, high phosphorylation levels of Akt were maintained, enabling S1P-mediated NF-κB signaling. In accord, inhibition of Akt suppressed S1P-mediated IKK and p65 phosphorylation and degradation of IκBα. Hence, these results support a negative role of FLNA in S1P-mediated NF-κB activation in melanoma cells through modulation of Akt.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26552704      PMCID: PMC4719300          DOI: 10.1128/MCB.00554-15

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  43 in total

1.  Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation.

Authors:  A D Kohn; S A Summers; M J Birnbaum; R A Roth
Journal:  J Biol Chem       Date:  1996-12-06       Impact factor: 5.157

2.  Sphingosine 1-phosphate analogs as receptor antagonists.

Authors:  Michael D Davis; Jeremy J Clemens; Timothy L Macdonald; Kevin R Lynch
Journal:  J Biol Chem       Date:  2004-12-08       Impact factor: 5.157

3.  Physical and functional interaction of filamin (actin-binding protein-280) and tumor necrosis factor receptor-associated factor 2.

Authors:  A Leonardi; H Ellinger-Ziegelbauer; G Franzoso; K Brown; U Siebenlist
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

Review 4.  The outs and the ins of sphingosine-1-phosphate in immunity.

Authors:  Sarah Spiegel; Sheldon Milstien
Journal:  Nat Rev Immunol       Date:  2011-05-06       Impact factor: 53.106

5.  Sphingosine kinase interacts with TRAF2 and dissects tumor necrosis factor-alpha signaling.

Authors:  Pu Xia; Lijun Wang; Paul A B Moretti; Nathaniel Albanese; Fugui Chai; Stuart M Pitson; Richard J D'Andrea; Jennifer R Gamble; Mathew A Vadas
Journal:  J Biol Chem       Date:  2002-01-02       Impact factor: 5.157

6.  Actin-binding protein requirement for cortical stability and efficient locomotion.

Authors:  C C Cunningham; J B Gorlin; D J Kwiatkowski; J H Hartwig; P A Janmey; H R Byers; T P Stossel
Journal:  Science       Date:  1992-01-17       Impact factor: 47.728

7.  Lysophospholipids increase ICAM-1 expression in HUVEC through a Gi- and NF-kappaB-dependent mechanism.

Authors:  Hsinyu Lee; Chi Iou Lin; Jia-Jun Liao; Yu-Wei Lee; Hsi Yuan Yang; Chung-Ying Lee; Hsien-Yeh Hsu; Hua Lin Wu
Journal:  Am J Physiol Cell Physiol       Date:  2004-08-04       Impact factor: 4.249

8.  Protein kinase Cdelta mediates lysophosphatidic acid-induced NF-kappaB activation and interleukin-8 secretion in human bronchial epithelial cells.

Authors:  Rhett Cummings; Yutong Zhao; David Jacoby; E William Spannhake; Motoi Ohba; Joe G N Garcia; Tonya Watkins; Donghong He; Bahman Saatian; Viswanathan Natarajan
Journal:  J Biol Chem       Date:  2004-07-26       Impact factor: 5.157

9.  Transient and selective NF-kappa B p65 serine 536 phosphorylation induced by T cell costimulation is mediated by I kappa B kinase beta and controls the kinetics of p65 nuclear import.

Authors:  Ivan Mattioli; Andrea Sebald; Cyril Bucher; Roch-Philippe Charles; Hiroyasu Nakano; Takahiro Doi; Michael Kracht; M Lienhard Schmitz
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

10.  TRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-kappaB activation.

Authors:  S Y Lee; S Y Lee; Y Choi
Journal:  J Exp Med       Date:  1997-04-07       Impact factor: 14.307

View more
  9 in total

Review 1.  S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy.

Authors:  Narges Rostami; Afshin Nikkhoo; Amir Ajjoolabady; Gholamreza Azizi; Mohammad Hojjat-Farsangi; Ghasem Ghalamfarsa; Bahman Yousefi; Mehdi Yousefi; Farhad Jadidi-Niaragh
Journal:  Mol Diagn Ther       Date:  2019-08       Impact factor: 4.074

2.  Rapid emergence and mechanisms of resistance by U87 glioblastoma cells to doxorubicin in an in vitro tumor microfluidic ecology.

Authors:  Jeonghun Han; Yukyung Jun; So Hyun Kim; Hong-Hoa Hoang; Yeonjoo Jung; Suyeon Kim; Jaesang Kim; Robert H Austin; Sanghyuk Lee; Sungsu Park
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-22       Impact factor: 11.205

3.  ROR2 promotes epithelial-mesenchymal transition by hyperactivating ERK in melanoma.

Authors:  María Victoria Castro; Gastón Alexis Barbero; Paula Máscolo; María Belén Villanueva; Jérémie Nsengimana; Julia Newton-Bishop; Edith Illescas; María Josefina Quezada; Pablo Lopez-Bergami
Journal:  J Cell Commun Signal       Date:  2022-06-20       Impact factor: 5.782

Review 4.  Sphingosine-1 Phosphate: A New Modulator of Immune Plasticity in the Tumor Microenvironment.

Authors:  Yamila I Rodriguez; Ludmila E Campos; Melina G Castro; Ahmed Aladhami; Carole A Oskeritzian; Sergio E Alvarez
Journal:  Front Oncol       Date:  2016-10-17       Impact factor: 6.244

Review 5.  Significance of 5-S-Cysteinyldopa as a Marker for Melanoma.

Authors:  Kazumasa Wakamatsu; Satoshi Fukushima; Akane Minagawa; Toshikazu Omodaka; Tokimasa Hida; Naohito Hatta; Minoru Takata; Hisashi Uhara; Ryuhei Okuyama; Hironobu Ihn
Journal:  Int J Mol Sci       Date:  2020-01-09       Impact factor: 5.923

Review 6.  Sphingosine 1-Phosphate (S1P)/ S1P Receptor Signaling and Mechanotransduction: Implications for Intrinsic Tissue Repair/Regeneration.

Authors:  Chiara Sassoli; Federica Pierucci; Sandra Zecchi-Orlandini; Elisabetta Meacci
Journal:  Int J Mol Sci       Date:  2019-11-07       Impact factor: 5.923

7.  ROR2 has a protective role in melanoma by inhibiting Akt activity, cell-cycle progression, and proliferation.

Authors:  María Victoria Castro; Gastón Alexis Barbero; María Belén Villanueva; Luca Grumolato; Jérémie Nsengimana; Julia Newton-Bishop; Edith Illescas; María Josefina Quezada; Pablo Lopez-Bergami
Journal:  J Biomed Sci       Date:  2021-11-13       Impact factor: 8.410

8.  Prion protein is required for tumor necrosis factor α (TNFα)-triggered nuclear factor κB (NF-κB) signaling and cytokine production.

Authors:  Gui-Ru Wu; Tian-Chen Mu; Zhen-Xing Gao; Jun Wang; Man-Sun Sy; Chao-Yang Li
Journal:  J Biol Chem       Date:  2017-09-12       Impact factor: 5.157

9.  Changes of Foxo3a in PBMCs and its associations with stress hyperglycemia in acute obstructive suppurative cholangitis patients.

Authors:  Niu Bailin; Chen Nan; Li Peizhi; He Kun; Zhu Xiwen; Ren Guosheng; Gong Jianping; Zhang Wenfeng
Journal:  Oncotarget       Date:  2017-08-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.